Sucampo Pharmaceuticals Set to Join S&P SmallCap 600 PR Newswire NEW YORK, Feb. 17, 2017 NEW YORK, Feb. 17, 2017 /PRNewswire/ -- Sucampo Pharmaceuticals Inc. (NASD: SCMP) will replace Blue...
SEATTLE, Feb. 17, 2017 (GLOBE NEWSWIRE) -- Leading online jeweler Blue Nile (NASDAQ:NILE) today announced the successful completion of the acquisition of the Company by an Investor Group...
NEW YORK, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Blue Nile (NASDAQ:NILE), a leading online jeweler, announced today that it has partnered with Mondiamo, an innovative e-commerce company, to...
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of The Board of Directors of Blue Nile - NILE PR Newswire NEW YORK, Dec. 2, 2016 NEW YORK, Dec. 2, 2016 /PRNewswire/...
Lifshitz & Miller Law Firm Announces Investigation of Alexion Pharmaceuticals, Inc., Blue Nile, Inc., Hill International, Inc., InfuSystem Holdings Inc., Rent-A-Center, Inc., Treehouse Foods...
ADVISORY, Nov. 25, 2016 (GLOBE NEWSWIRE) -- What:Blue Nile, Inc. (Nasdaq:NILE), a leading online retailer of diamonds and fine jewelry, will visit the Nasdaq MarketSite in Times Square...
SEATTLE, Nov. 22, 2016 (GLOBE NEWSWIRE) -- Leading online jeweler Blue Nile (NASDAQ:NILE) today opened its fifth Webroom location; this one at Bellevue Square in Bellevue, Washington, just a...
SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Blue Nile, Inc. -NILE PR Newswire BALA CYNWYD, Pa., Nov. 17, 2016 BALA CYNWYD, Pa., Nov. 17...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Blue Nile Inc. to a Consortium for $40.75 Per Share is Fair to Shareholders -- NILE PR...
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales